United Therapeutics Corporation · NASDAQ:UTHR

Rothblatt Martine A sold 9,500 United Therapeutics Corporation shares (Form 4)

Traded Apr 20, 2026 · Filed Apr 21, 2026

On Apr 20, 2026, Rothblatt Martine A (Director, Chairperson & CEO) sold 9,500 United Therapeutics Corporation shares at an average US$577.83 for US$5.49M under a trading plan, leaving 40,513 shares. Filed Apr 21, 2026 (Form 4).

Sold
9,500 shares
Price
US$577.83 average (US$572.41 to US$586.47)
Value
US$5.49M
Holding after
40,513 shares
Trading plan
Yes (Made under a plan set in advance)
Role
Director, Chairperson & CEO

The filing in full

DateSecurityTransactionSharesPriceHolding afterOwnership
Apr 20, 2026Common StockOption exercise9,500US$146.0350,013Direct
Apr 20, 2026Common StockSale977US$572.4149,036Direct
Apr 20, 2026Common StockSale1,683US$573.5747,353Direct
Apr 20, 2026Common StockSale570US$575.0746,783Direct
Apr 20, 2026Common StockSale1,179US$575.9645,604Direct
Apr 20, 2026Common StockSale1,148US$576.8744,456Direct
Apr 20, 2026Common StockSale165US$577.9444,291Direct
Apr 20, 2026Common StockSale461US$579.0943,830Direct
Apr 20, 2026Common StockSale277US$579.9243,553Direct
Apr 20, 2026Common StockSale410US$581.7143,143Direct
Apr 20, 2026Common StockSale1,070US$582.4642,073Direct
Apr 20, 2026Common StockSale848US$583.4141,225Direct
Apr 20, 2026Common StockSale509US$584.3940,716Direct
Apr 20, 2026Common StockSale163US$585.5040,553Direct
Apr 20, 2026Common StockSale40US$586.4740,513Direct

Source

View original at SEC

Related